Grants and Contributions:
Title:
Development of Novel Diagnostics Leveraging AI-Generated Peptides as Key Biological Components
Agreement Number:
1037163
Agreement Value:
$80,258.00
Agreement Date:
Nov 3, 2025 - Aug 31, 2026
Description:
Precision BioLogic (PBI) develops, manufactures and distributes in vitro diagnostic products that address unmet needs in the diagnosis and management of human blood coagulation disorders. PBI is leveraging a novel AI-based technology to develop key immunoassay biologics for diagnosis of emerging thrombotic conditions. This innovative approach will enable efficient creation of assays with superior performance characteristics and hence empower health providers to make the best decisions, faster.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Dartmouth, Nova Scotia, CA B3B 0A9
Reference Number:
172-2025-2026-Q3-1037163
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
104288360
Recipient Type:
For-profit organization
Recipient's Legal Name:
Precision BioLogic Incorporated
Federal Riding Name:
Dartmouth--Cole Harbour
Federal Riding Number:
12004
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110